Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker RAPP
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Abraham N. Ceesay Officer | RAPP Rapport Therapeutics, Inc. | 39,470 | $1.2M | 10b5-1 | Oct 6, 2026 | Form 4 ↗ 17 days later · 2,210 shares | Form 144 ↗ |
| Sep 30, 2026 | Cheryl Gault Officer | RAPP Rapport Therapeutics, Inc. | 10,000 | $330.2K | 10b5-1 | Sep 30, 2026 | — | Form 144 ↗ |
| Aug 25, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 37,000 | $1.8M | 10b5-1 | Aug 25, 2026 | Form 4 ↗ 1 day later · 50,160 shares | Form 144 ↗ |
| Aug 24, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 11,472 | $553.4K | 10b5-1 | Aug 24, 2026 | Form 4 ↗ 2 days later · 50,160 shares | Form 144 ↗ |
| Aug 19, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 2,092 | $102.5K | 10b5-1 | Aug 19, 2026 | Form 4 ↗ 1 day later · 404 shares | Form 144 ↗ |
| Jun 30, 2026 | Cheryl Gault Officer | RAPP Rapport Therapeutics, Inc. | 10,000 | $403.9K | 10b5-1 | Jun 30, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jun 29, 2026 | Abraham N. Ceesay Officer | RAPP Rapport Therapeutics, Inc. | 99,480 | $4.0M | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 2 days later · 8,220 shares | Form 144 ↗ |
| May 27, 2026 | Third Rock Ventures V, L.P. 10% Stockholder | RAPP Rapport Therapeutics, Inc. | 18,572 | $742.9K | — | May 26, 2026 | Form 4 ↗ 1 day later · 18,572 shares | Form 144 ↗ |
| May 11, 2026 | Third Rock Ventures V, L.P. 10% Stockholder | RAPP Rapport Therapeutics, Inc. | 133,618 | $5.4M | 10b5-1 | May 11, 2026 | Form 4 ↗ 2 days later · 133,618 shares | Form 144 ↗ |
| May 8, 2026 | Third Rock Ventures V, L.P. 10% Stockholder | RAPP Rapport Therapeutics, Inc. | 5,018 | $202.3K | 10b5-1 | May 8, 2026 | Form 4 ↗ 3 days later · 276,513 shares | Form 144 ↗ |
| May 7, 2026 | Third Rock Ventures V, L.P. 10% Stockholder | RAPP Rapport Therapeutics, Inc. | 271,495 | $10.9M | 10b5-1 | May 7, 2026 | Form 4 ↗ 4 days later · 276,513 shares | Form 144 ↗ |
| Apr 17, 2026 | Third Rock Ventures V, L.P. 10% Stockholder | RAPP Rapport Therapeutics, Inc. | 426,005 | $17.2M | 10b5-1 | Apr 17, 2026 | Form 4 ↗ 4 days later · 426,005 shares | Form 144 ↗ |
| Apr 17, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 20,225 | $799.7K | 10b5-1 | Apr 17, 2026 | Form 4 ↗ 4 days later · 20,225 shares | Form 144 ↗ |
| Apr 13, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 19,365 | $661.7K | 10b5-1 | Apr 13, 2026 | Form 4 ↗ 1 day later · 19,865 shares | Form 144 ↗ |
| Apr 10, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 500 | $17.1K | 10b5-1 | Apr 10, 2026 | Form 4 ↗ 4 days later · 19,865 shares | Form 144 ↗ |
| Apr 8, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 360 | $12.1K | 10b5-1 | Apr 8, 2026 | Form 4 ↗ 1 day later · 360 shares | Form 144 ↗ |
| Mar 30, 2026 | Cheryl Gault Officer | RAPP Rapport Therapeutics, Inc. | 10,000 | $278.4K | 10b5-1 | Mar 30, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Mar 25, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 10,115 | $285.7K | 10b5-1 | Mar 25, 2026 | Form 4 ↗ 1 day later · 10,115 shares | Form 144 ↗ |
| Mar 5, 2026 | Cheryl Gault Officer | RAPP Rapport Therapeutics, Inc. | 2,014 | $58.2K | — | Mar 5, 2026 | Form 4 ↗ 4 days later · 2,014 shares | Form 144 ↗ |
| Jan 15, 2026 | David Bredt Officer | RAPP Rapport Therapeutics, Inc. | 17,000 | $466.1K | 10b5-1 | Jan 15, 2026 | Form 4 ↗ 1 day later · 8,500 shares | Form 144 ↗ |
| Jan 2, 2026 | David Bredt Officer | RAPP Rapport Therapeutics, Inc. | 6,567 | $197.3K | — | Jan 2, 2026 | Form 4 ↗ 14 days later · 8,500 shares | Form 144 ↗ |
| Jan 2, 2026 | Krishnaswamy Yeleswaram Officer | RAPP Rapport Therapeutics, Inc. | 2,840 | $85.3K | — | Jan 2, 2026 | Form 4 ↗ 83 days later · 10,115 shares | Form 144 ↗ |
| Dec 17, 2025 | The Dorothy Ceesay Irrevocable Trust Director, Officer | RAPP Rapport Therapeutics, Inc. | 15,249 | $469.1K | 10b5-1 | Dec 17, 2025 | Form 4 ↗ 1 day later · 10,916 shares | Form 144 ↗ |
| Dec 17, 2025 | Abraham Ceesay Director, Officer | RAPP Rapport Therapeutics, Inc. | 17,499 | $538.3K | 10b5-1 | Dec 17, 2025 | Form 4 ↗ 1 day later · 10,916 shares | Form 144 ↗ |
| Oct 15, 2025 | David Bredt Officer | RAPP Rapport Therapeutics, Inc. | 25,500 | $634.4K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ 1 day later · 8,500 shares | Form 144 ↗ |
| Sep 17, 2025 | Abraham Ceesay Director, Officer | RAPP Rapport Therapeutics, Inc. | 52,501 | $1.4M | 10b5-1 | Sep 17, 2025 | Form 4 ↗ 2 days later · 76,420 shares | Form 144 ↗ |
| Sep 17, 2025 | The Dorothy Ceesay Irrev Trust U/Adtd 03/27/2024 Director, Officer | RAPP Rapport Therapeutics, Inc. | 45,751 | $1.2M | 10b5-1 | Sep 17, 2025 | Form 4 ↗ 2 days later · 76,420 shares | Form 144 ↗ |
| Sep 8, 2025 | Cheryl Gault Officer | RAPP Rapport Therapeutics, Inc. | 10,000 | $143.6K | 10b5-1 | Sep 8, 2025 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Jun 16, 2025 | David Bredt Officer | RAPP Rapport Therapeutics, Inc. | 34,000 | $380.5K | 10b5-1 | Jun 16, 2025 | Form 4 ↗ 2 days later · 8,500 shares | Form 144 ↗ |
| Mar 14, 2025 | David Bredt Officer | RAPP Rapport Therapeutics, Inc. | 25,500 | $255.5K | 10b5-1 | Mar 14, 2025 | Form 4 ↗ 3 days later · 8,500 shares | Form 144 ↗ |
30 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances